
Christopher M. Gross
Examiner (ID: 18565, Phone: (571)272-4446 , Office: P/1639 )
| Most Active Art Unit | 1639 |
| Art Unit(s) | 1675, 1639, 1684, 1636 |
| Total Applications | 900 |
| Issued Applications | 468 |
| Pending Applications | 125 |
| Abandoned Applications | 336 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17505130
[patent_doc_number] => 20220098232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => Multicyclic Peptides and Methods for Their Preparation
[patent_app_type] => utility
[patent_app_number] => 17/494149
[patent_app_country] => US
[patent_app_date] => 2021-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17494149
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/494149 | Multicyclic Peptides and Methods for Their Preparation | Oct 4, 2021 | Pending |
Array
(
[id] => 17505130
[patent_doc_number] => 20220098232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => Multicyclic Peptides and Methods for Their Preparation
[patent_app_type] => utility
[patent_app_number] => 17/494149
[patent_app_country] => US
[patent_app_date] => 2021-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17494149
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/494149 | Multicyclic Peptides and Methods for Their Preparation | Oct 4, 2021 | Pending |
Array
(
[id] => 17505130
[patent_doc_number] => 20220098232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => Multicyclic Peptides and Methods for Their Preparation
[patent_app_type] => utility
[patent_app_number] => 17/494149
[patent_app_country] => US
[patent_app_date] => 2021-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17494149
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/494149 | Multicyclic Peptides and Methods for Their Preparation | Oct 4, 2021 | Pending |
Array
(
[id] => 17807751
[patent_doc_number] => 20220259586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => SINGLE CELL ANALYSIS OF TRANSPOSASE ACCESSIBLE CHROMATIN
[patent_app_type] => utility
[patent_app_number] => 17/492536
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52955
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17492536
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/492536 | Single cell analysis of transposase accessible chromatin | Sep 30, 2021 | Issued |
Array
(
[id] => 17370304
[patent_doc_number] => 20220025356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => HIGH THROUGHPUT PROTEIN-PROTEIN INTERACTION SCREENING IN YEAST LIQUID CULTURE
[patent_app_type] => utility
[patent_app_number] => 17/480078
[patent_app_country] => US
[patent_app_date] => 2021-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34153
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17480078
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/480078 | High throughput protein-protein interaction screening in yeast liquid culture | Sep 19, 2021 | Issued |
Array
(
[id] => 18972249
[patent_doc_number] => 20240052341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => MAMMALIAN CELLS AND METHODS FOR ENGINEERING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/023909
[patent_app_country] => US
[patent_app_date] => 2021-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86763
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18023909
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/023909 | MAMMALIAN CELLS AND METHODS FOR ENGINEERING THE SAME | Aug 31, 2021 | Pending |
Array
(
[id] => 17400012
[patent_doc_number] => 20220042102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => MIRNA FINGERPRINT IN THE DIAGNOSIS OF LUNG CANCER
[patent_app_type] => utility
[patent_app_number] => 17/392534
[patent_app_country] => US
[patent_app_date] => 2021-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10787
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17392534
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/392534 | MIRNA FINGERPRINT IN THE DIAGNOSIS OF LUNG CANCER | Aug 2, 2021 | Pending |
Array
(
[id] => 17400012
[patent_doc_number] => 20220042102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => MIRNA FINGERPRINT IN THE DIAGNOSIS OF LUNG CANCER
[patent_app_type] => utility
[patent_app_number] => 17/392534
[patent_app_country] => US
[patent_app_date] => 2021-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10787
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17392534
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/392534 | MIRNA FINGERPRINT IN THE DIAGNOSIS OF LUNG CANCER | Aug 2, 2021 | Pending |
Array
(
[id] => 17461641
[patent_doc_number] => 20220074946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => PEPTIDE ARRAY QUALITY CONTROL
[patent_app_type] => utility
[patent_app_number] => 17/305975
[patent_app_country] => US
[patent_app_date] => 2021-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17305975
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/305975 | PEPTIDE ARRAY QUALITY CONTROL | Jul 18, 2021 | Abandoned |
Array
(
[id] => 18838572
[patent_doc_number] => 11846639
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-19
[patent_title] => Ligand discovery for T cell receptors
[patent_app_type] => utility
[patent_app_number] => 17/378310
[patent_app_country] => US
[patent_app_date] => 2021-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 17
[patent_no_of_words] => 21569
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 329
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17378310
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/378310 | Ligand discovery for T cell receptors | Jul 15, 2021 | Issued |
Array
(
[id] => 17336576
[patent_doc_number] => 20220002907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => NUCLEIC ACID-GUIDED EDITING OF EXOGENOUS POLYNUCLEOTIDES IN HETEROLOGOUS CELLS
[patent_app_type] => utility
[patent_app_number] => 17/377272
[patent_app_country] => US
[patent_app_date] => 2021-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41117
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 321
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17377272
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/377272 | Nucleic acid-guided editing of exogenous polynucleotides in heterologous cells | Jul 14, 2021 | Issued |
Array
(
[id] => 19326162
[patent_doc_number] => 12043828
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-23
[patent_title] => Methods for labeling DNA fragments to reconstruct physical linkage and phase
[patent_app_type] => utility
[patent_app_number] => 17/373736
[patent_app_country] => US
[patent_app_date] => 2021-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 17
[patent_no_of_words] => 34089
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17373736
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/373736 | Methods for labeling DNA fragments to reconstruct physical linkage and phase | Jul 11, 2021 | Issued |
Array
(
[id] => 17336455
[patent_doc_number] => 20220002786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF SEPSIS USING GAMMA PEPTIDE NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 17/370819
[patent_app_country] => US
[patent_app_date] => 2021-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13046
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17370819
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/370819 | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF SEPSIS USING GAMMA PEPTIDE NUCLEIC ACIDS | Jul 7, 2021 | Pending |
Array
(
[id] => 17336455
[patent_doc_number] => 20220002786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF SEPSIS USING GAMMA PEPTIDE NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 17/370819
[patent_app_country] => US
[patent_app_date] => 2021-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13046
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17370819
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/370819 | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF SEPSIS USING GAMMA PEPTIDE NUCLEIC ACIDS | Jul 7, 2021 | Pending |
Array
(
[id] => 17358052
[patent_doc_number] => 20220018848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => METHODS OF SCREENING
[patent_app_type] => utility
[patent_app_number] => 17/363938
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8522
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17363938
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/363938 | Methods of screening | Jun 29, 2021 | Issued |
Array
(
[id] => 17157280
[patent_doc_number] => 20210318331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => COMBINATORIAL ANTIBODY DIAGNOSTIC
[patent_app_type] => utility
[patent_app_number] => 17/355707
[patent_app_country] => US
[patent_app_date] => 2021-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17355707
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/355707 | COMBINATORIAL ANTIBODY DIAGNOSTIC | Jun 22, 2021 | Abandoned |
Array
(
[id] => 17369934
[patent_doc_number] => 20220024986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => MOLECULAR SIGNATURE GENERATION
[patent_app_type] => utility
[patent_app_number] => 17/342938
[patent_app_country] => US
[patent_app_date] => 2021-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7259
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17342938
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/342938 | MOLECULAR SIGNATURE GENERATION | Jun 8, 2021 | Abandoned |
Array
(
[id] => 17298339
[patent_doc_number] => 20210394178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => OLIGONUCLEOTIDE ENCODED CHEMICAL LIBRARIES
[patent_app_type] => utility
[patent_app_number] => 17/236283
[patent_app_country] => US
[patent_app_date] => 2021-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61788
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17236283
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/236283 | Oligonucleotide encoded chemical libraries | Apr 20, 2021 | Issued |
Array
(
[id] => 17022703
[patent_doc_number] => 20210246574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => NUCLEIC ACID-GUIDED EDITING OF EXOGENOUS POLYNUCLEOTIDES IN HETEROLOGOUS CELLS
[patent_app_type] => utility
[patent_app_number] => 17/232046
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41023
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 323
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17232046
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/232046 | Nucleic acid-guided editing of exogenous polynucleotides in heterologous cells | Apr 14, 2021 | Issued |
Array
(
[id] => 18036539
[patent_doc_number] => 20220380754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => High-Throughput Screening Methods to Identify Small Molecule Targets
[patent_app_type] => utility
[patent_app_number] => 17/607801
[patent_app_country] => US
[patent_app_date] => 2021-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 342
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17607801
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/607801 | High-Throughput Screening Methods to Identify Small Molecule Targets | Apr 12, 2021 | Pending |